Alpha Omega Wealth Management LLC Has $2.05 Million Stake in Ralliant Corporation $RAL

Key Points

• Alpha Omega Wealth Management increased its stake in Ralliant by 615.8% in Q4 to 40,291 shares, valued at about $2.05 million.
• Analyst views are mixed—several downgrades and upgrades result in a MarketBeat consensus rating of "Hold" with an average price target of $50.50.
• Ralliant slightly beat Q4 estimates (EPS $0.69 vs $0.67; revenue $554.6M vs $543.0M), provided Q1 2026 guidance of $0.460–0.520 and FY2026 guidance of $2.220–2.420 EPS, and pays a small annualized dividend (~$0.20, ~0.4% yield).

Alpha Omega Wealth Management LLC boosted its stake in Ralliant Corporation (NYSE:RAL - Free Report) by 615.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,291 shares of the company's stock after acquiring an additional 34,662 shares during the quarter. Alpha Omega Wealth Management LLC's holdings in Ralliant were worth $2,051,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. Cetera Investment Advisers acquired a new stake in Ralliant in the 2nd quarter valued at approximately $700,000. Russell Investments Group Ltd. acquired a new stake in Ralliant in the 2nd quarter valued at approximately $1,465,000. M&T Bank Corp acquired a new stake in Ralliant in the 2nd quarter valued at approximately $425,000. EverSource Wealth Advisors LLC acquired a new stake in Ralliant in the 2nd quarter valued at approximately $39,000. Finally, First Trust Advisors LP acquired a new stake in Ralliant in the 2nd quarter valued at approximately $2,013,000.

Analysts Set New Price Targets

RAL has been the topic of several recent analyst reports. Weiss Ratings lowered Ralliant from a "hold (c)" rating to a "sell (d)" rating in a research report on Thursday, February 5th. Zacks Research lowered Ralliant from a "hold" rating to a "strong sell" rating in a research report on Monday, February 9th. Royal Bank Of Canada lowered their price target on Ralliant from $52.00 to $41.00 and set a "sector perform" rating on the stock in a research report on Friday, February 6th. Truist Financial lowered their price target on Ralliant from $62.00 to $49.00 and set a "buy" rating on the stock in a research report on Friday, February 6th. Finally, Vertical Research raised Ralliant from a "hold" rating to a "buy" rating and set a $45.00 price target on the stock in a research report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Ralliant presently has a consensus rating of "Hold" and an average target price of $50.50.

Ralliant Stock Performance

NYSE:RAL opened at $44.61 on Friday. The stock has a fifty day moving average price of $44.14 and a 200-day moving average price of $46.66. The company has a market cap of $4.99 billion and a price-to-earnings ratio of 22.76. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $57.02.

Ralliant (NYSE:RAL - Get Free Report) last released its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts' consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The company's revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant's payout ratio is 10.20%.

Insiders Place Their Bets

In related news, Director Anelise Angelino Sacks purchased 2,000 shares of the firm's stock in a transaction dated Monday, February 9th. The stock was bought at an average price of $41.25 per share, with a total value of $82,500.00. Following the completion of the purchase, the director owned 5,403 shares in the company, valued at approximately $222,873.75. This represents a 58.77% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Karen M. Bick sold 5,485 shares of the stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total value of $246,825.00. Following the completion of the sale, the senior vice president directly owned 46,756 shares of the company's stock, valued at approximately $2,104,020. The trade was a 10.50% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have acquired 8,145 shares of company stock worth $332,233.

Ralliant Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.